Aromatase inhibitors for infertility in polycystic ovary syndrome. The beginning or the end of a new era?

Nikolaos P Polyzos; Maria Tsappi; Davide Mauri; Vedat Atay; Ivan Cortinovis; Giovanni Casazza

doi:10.1016/j.fertnstert.2007.10.016

Aromatase inhibitors for infertility in polycystic ovary syndrome. The beginning or the end of a new era?

Fertil Steril. 2008 Feb;89(2):278-80. doi: 10.1016/j.fertnstert.2007.10.016.

Authors

Nikolaos P Polyzos¹, Maria Tsappi, Davide Mauri, Vedat Atay, Ivan Cortinovis, Giovanni Casazza

Affiliation

¹ PACMeR (PanHellenic Association for Continual Medical Research), Section of Obstetrics and Gynaecology, Athens, Greece. n.polyzos@gmail.com

PMID: 18275882
DOI: 10.1016/j.fertnstert.2007.10.016

Abstract

A meta-analysis of four trials showed significant advantage in pregnancy and delivery rates with aromatase inhibitors compared with CC in women with PCOS. A recent randomized trial demonstrated no clear benefit.

Publication types

Meta-Analysis

MeSH terms

Aromatase Inhibitors / therapeutic use*
Clinical Trials as Topic
Female
Humans
Infertility, Female / drug therapy*
Infertility, Female / etiology*
Ovulation Induction / methods
Ovulation Induction / trends*
Polycystic Ovary Syndrome / complications*
Pregnancy

Substances

Aromatase Inhibitors